Prognosis of Idiopathic CD4 Lymphocytopenia in childre

Withdrawn

• Conditions: ICL; Idiopatische CD4 lymphopenia; 10047954; 10021429

• Registration Number: NL-OMON38721
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

- Age between 0 to 16
- Lymphopenic two or more occasions, separated by at least a month (identified by pre-clinical screening, see research protocol)
- Good understanding of the Dutch language

Exclusion Criteria

- Immunosuppressive co-morbidities explaining lymphopenia
- Immunosuppressive medication explaining lymphopenia
- Unavailability for follow-up research (immigration, mortality)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- CD4 cell counts<br /><br><br /><br>- Medical history defined by the questionnaire and medical files provided by<br /><br>the general practitioner.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Number of first degree family members affected by ICL.</p><br>